GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (WBO:LLYC) » Definitions » Shiller PE Ratio

Eli Lilly and Co (WBO:LLYC) Shiller PE Ratio : 139.86 (As of May. 05, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Eli Lilly and Co Shiller PE Ratio?

As of today (2024-05-05), Eli Lilly and Co's current share price is €682.50. Eli Lilly and Co's E10 for the quarter that ended in Mar. 2024 was €4.88. Eli Lilly and Co's Shiller PE Ratio for today is 139.86.

The historical rank and industry rank for Eli Lilly and Co's Shiller PE Ratio or its related term are showing as below:

WBO:LLYC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.02   Med: 31.45   Max: 154.88
Current: 141

During the past years, Eli Lilly and Co's highest Shiller PE Ratio was 154.88. The lowest was 16.02. And the median was 31.45.

WBO:LLYC's Shiller PE Ratio is ranked worse than
94.75% of 533 companies
in the Drug Manufacturers industry
Industry Median: 25.13 vs WBO:LLYC: 141.00

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Mar. 2024 was €2.282. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €4.88 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eli Lilly and Co Shiller PE Ratio Historical Data

The historical data trend for Eli Lilly and Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Shiller PE Ratio Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.70 42.58 63.05 74.95 115.37

Eli Lilly and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.68 93.19 109.07 115.37 149.25

Competitive Comparison of Eli Lilly and Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.



Eli Lilly and Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=682.50/4.88
=139.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.282/129.4194*129.4194
=2.282

Current CPI (Mar. 2024) = 129.4194.

Eli Lilly and Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.500 100.560 0.643
201409 0.365 100.428 0.470
201412 0.313 99.070 0.409
201503 0.462 99.621 0.600
201506 0.499 100.684 0.641
201509 0.668 100.392 0.861
201512 0.397 99.792 0.515
201603 0.368 100.470 0.474
201606 0.632 101.688 0.804
201609 0.650 101.861 0.826
201612 0.665 101.863 0.845
201703 -0.093 102.862 -0.117
201706 0.846 103.349 1.059
201709 0.445 104.136 0.553
201712 -1.335 104.011 -1.661
201803 0.941 105.290 1.157
201806 -0.214 106.317 -0.261
201809 0.960 106.507 1.167
201812 0.936 105.998 1.143
201903 3.814 107.251 4.602
201906 1.274 108.070 1.526
201909 1.244 108.329 1.486
201912 1.406 108.420 1.678
202003 1.448 108.902 1.721
202006 1.376 108.767 1.637
202009 1.129 109.815 1.331
202012 1.819 109.897 2.142
202103 1.252 111.754 1.450
202106 1.270 114.631 1.434
202109 1.037 115.734 1.160
202112 1.602 117.630 1.763
202203 1.907 121.301 2.035
202206 0.993 125.017 1.028
202209 1.626 125.227 1.680
202212 1.925 125.222 1.990
202303 1.392 127.348 1.415
202306 1.800 128.729 1.810
202309 -0.056 129.860 -0.056
202312 2.115 129.419 2.115
202403 2.282 129.419 2.282

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eli Lilly and Co  (WBO:LLYC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Eli Lilly and Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co (WBO:LLYC) Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Co (WBO:LLYC) Headlines

No Headlines